January 26, 2026
Primmune Therapeutics
Primmune Therapeutics is a Biotechnology company.
- Round
- Series B
- Amount raised
- $23.3M
- Lead investor
- Bioqube Ventures
- Industry
- Biotechnology
- Headquarters
- San Diego, California
- Employees
- 1-10
- Website
- www.primmunerx.com
- —
Other investors
- CAM Capital